from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3912/-

LFCtreatmentdescriptionclass of inhibitor

-0.047

Amikacinug/mL Amikacintranslation

-0.036

Cap5-10ug/mL Capreomycintranslation

0.475

Rox10-50 ug/mL Roxithromycintranslation

0.136

SM2-5 ug/mL Streptomycintranslation

2.607

Tet5-10 ug/mL Tetracyclinetranslation

1.273

Rif0.2-5ug/mL Rifampicintranscription

0.307

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.792

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.711

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.087

CPZ10-50 ug/mL Chlorpromazinerespiration

0.059

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.289

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.449

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.910

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.194

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.634

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.118

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.424

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.035

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.185

KCN5-20 ug/mL Potassium cyaniderespiration

1.862

NaN30.2-2 mM Sodium aziderespiration

0.977

Nigericin50 uM Nigericinrespiration

-0.706

TRC10-150 ug/mL Triclosanrespiration

-1.019

TRZ10-25 ug/mL Thioridazinerespiration

1.413

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.361

menadione6-10 ug/mL Menadionerespiration

-0.192

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.045

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.260

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.738

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.153

NRP_1Non-replicating persistence stage 1dosRassociated

0.088

Amp0.2mg/mL AmpicillincellWall

0.060

Cephalexin20-100 ug/mL CephalexincellWall

0.969

Cerulenin0.32-5 ug/mL CerulenincellWall

0.444

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.072

EMB10-20 ug/mL EthambutolcellWall

-0.058

Eta12-40 ug/mL EthionamidecellWall

-0.351

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.431

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.452

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.593

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.746

BZA0.12 mg/mL BenzamidearomaticAmides

-0.080

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.372

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.228

H2O24 mM hydrogen peroxideDNAdamaging

-0.329

Levo10 ug/mL LevofloxacinDNAdamaging

-0.092

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.997

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.054

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.237

UVUV-irradiationDNAdamaging

0.537

ARP41-4 ug/mL Antitubercular compound ARP4?

0.376

Antimycin12.5-50 ug/mL Antimycin A?

0.120

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.370

PA_110-50 ug/mL Antitubercular compound PA-1?

0.175

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.051

PA8240.2-2 ug/mL PA-824?

0.241

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.059

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.719

Verapamil50 uM Verapamil?

0.306

mercaptoethanol2 mM 2-Mercaptoethanol?

0.759

methoxatin10-20 ug/mL Methoxatin?